CXCR3 Protein-VLP
Quick Overview for CXCR3 Protein-VLP (ABIN7488804)
Target
See all CXCR3 ProteinsProtein Type
Origin
Source
-
-
Purpose
- Human CXCR3 Full Length Protein (VLP)
-
Sequence
- Val 2 - Leu 368
-
Characteristics
- Human CXCR3 Full Length Protein-VLP is expressed from human 293 cells (HEK293). It contains AA Val 2 - Leu 368 (Accession # P49682-1).
-
Endotoxin Level
- 1.0 EU per μg
-
-
Want other Options for this Protein ?
!Discover Our Predefined Custom Proteins and Custom Protein Services!ProductExpression SystemConjugateOriginPrice starts atExpression System HEK-293 CellsConjugate His tagOrigin HumanPrice starts at $16,231.82Expression System Cell-free protein synthesis (CFPS)Conjugate Strep TagOrigin HumanPrice starts at $18,117.43Your project requires further customization? Contact us and discover our custom protein solutions
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS, Arginine, pH 7.4
-
Storage
- -80 °C
-
Storage Comment
- -70°C
-
-
- CXCR3 (Chemokine (C-X-C Motif) Receptor 3 (CXCR3))
-
Alternative Name
- CXCR3
-
Background
- Chemokines are proteins which induce chemotaxis, promote differentiation of immune cells, and cause tissue extravasation. Given these properties, their role in anti-tumor immune response in the cancer environment is of great interest. Although immunotherapy has shown clinical benefit for some cancer patients, other patients do not respond. One of the mechanisms of resistance to checkpoint inhibitors may be chemokine signaling. The CXCL9, -10, -11/CXCR3 axis regulates immune cell migration, differentiation, and activation, leading to tumor suppression (paracrine axis). However, there are some reports that show involvements of this axis in tumor growth and metastasis (autocrine axis). Thus, a better understanding of CXCL9, -10, -11/CXCR3 axis is necessary to develop effective cancer control.
Target
-